Curious about today's AI digest?ai-tldr.dev
Pomegra LogoPomegra

Daily Digest

BriefMarket · neutralLow impact
Esc
Traders at screens on the Deutsche Börse trading floor in Frankfurt
Photo: Investing.com

Corteva Stock Jumps 12% After JPMorgan Upgrade

Investing.com2 min read6 sources

Why did Corteva stock jump 12%?

Corteva (CTVA) stock rose 12% to $13.91 on Tuesday after JPMorgan upgraded it to Overweight with a $19 target, calling the shares undervalued following the Vylor seed spinoff.

Key numbers

Share price (Oct 6 close)$13.91+12.27%
JPMorgan price target$19.00from $83.00 pre-split
Market cap$9.3Bafter spinoff
Est. PFAS liability share$1.3Babout $2 per share
Valuation, 2027 EBITDA (est.)5.7xJPM fair value 10x

What happened

Corteva (CTVA) stock rose 12% to $13.91 on Tuesday after JPMorgan upgraded it to Overweight with a $19 target, calling the shares undervalued following the Vylor seed spinoff. Overweight means JPMorgan expects the shares to beat the market; it raised its view from Neutral. On 1 October Corteva split off its seed business into a new company, Vylor, leaving a smaller crop-chemicals business. It also moved from the S&P 500 to the S&P MidCap 400 on 6 October, which pushed index funds to buy.

Why it matters

Corteva is now a smaller company that sells crop-protection products, such as weed and insect killers, and investors are still working out what it is worth. JPMorgan sees fair value near $21 a share before legal costs, against $13.91 now. The big risk is lawsuits over PFAS, so-called forever chemicals, which JPMorgan estimates could cost Corteva about $1.3 billion. Fifteen states have also sued over the split.

Who this affects

Marketneutral
Low impact
Index funds bought Corteva; mid-cap investors gain a new name.
Companybullish
Medium impact
Shareholders gain; shares rebounded 12% but legal risk remains.
Competitorsneutral
Low impact
FMC and Bayer shares edged up slightly alongside Corteva.
Industryneutral
Low impact
Crop-protection pure plays draw fresh attention from analysts and investors.

Corteva vs FMC, Bayer

CortevaCTVA$9.3B+12.3%Crop protection
FMCFMC—Modest gainCrop protection
BayerBAYN.DE—Modest gainCrop science, pharma

As of 2026-10-06

How we got here

  1. Corteva completes Vylor seed spinoff; Corteva closes at $12.56, Vylor at $68.26.

  2. Fifteen states and Guam sue both companies over PFAS-related asset transfers.

  3. Corteva joins S&P MidCap 400 before the market opens.

  4. JPMorgan upgrades Corteva to Overweight with $19 target; shares close at $13.91.

What to watch

  • Corteva reports its first quarterly results since the split.2026-11-11
  • Court steps in the 15-state lawsuit over PFAS and the spinoff.Ongoing
  • Whether Corteva announces a dividend policy; none has been set yet.Not yet announced

Educational content only. Not investment advice.

More briefsAll briefs →